Clinical trial
A Phase 2 Study of Panitumumab in Patients With Cetuximab-refractory Metastatic Colorectal Cancer
NCT01801904 is registered in ClinicalTrials.gov with National Cancer Institute, Naples as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Study of Panitumumab in Patients With Cetuximab-refractory Metastatic Colorectal Cancer
- Lead sponsor
- National Cancer Institute, Naples
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- December 31, 2012
- Completion date
- December 31, 2024
- Enrollment
- 52 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
metastatic colorectal cancer